Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2010 | Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan. | Chang, HY; Hsu, CC; Pan, WH; Liu, WL; Cheng, JY; Tseng, CH; Bai, CH; Yeh, WT; Hurng, BS | Diabetes research and clinical practice 90(3), 358-364 | | | |
2019 | HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication. | Ogawa, E; Toyoda, H; Iio, E; Jun, DW; Huang, CF; Enomoto, M; Hsu, YC; Haga, H; Iwane, S; Wong, G; Lee, DH; Tada, T; Liu, CH; Chuang, WL; Hayashi, J; Cheung, R; Yasuda, S; Tseng, CH; Takahashi, H; Tran, S; Yeo, YH; Henry, L; Barnett, SD; Nomura, H; Nakamuta, M; Dai, CY; Huang, JF; Yang, HI ; Lee, MH; Jung Jun, M; Kao, JH; Eguchi, Y; Ueno, Y; Tamori, A; Furusyo, N; Yu, ML; Tanaka, Y; Nguyen, MH; Ahn, SB; Azuma, K; Dohmen, K; Yoon Jeong, J; Jung, JH; Kajiwara, E; Kato, M; Kawano, A; Koyanagi, T; Ooho, A; Park, SH; Satoh, T; Shimoda, S; Song, DS; Takahashi, K; Yeh, ML; Yoon, EL | Clinical Infectious Diseases, ciz1160 | | | |
2022 | Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis | Cheng, KW; Tseng, CH; Chen, IJ; Huang, BC; Liu, HJ; Ho, KW; Lin, WW; Chuang, CH; Huang, MY; Leu, YL; Roffler, SR ; Wang, JY; Chen, YL; Cheng, TL | Pharmacological research 177, 106115 | | | |
2010 | Modification of Small Hepatitis Delta Virus Antigen by SUMO Protein | Tseng, CH; Cheng, TS; Shu, CY; Jeng, KS ; Lai, MM | Journal of Virology 84(2), 918-927 | | | |
2010 | Optimal anthropometric factor cutoffs for hyperglycemia, hypertension and dyslipidemia for the Taiwanese population | Tseng, CH; Chong, CK; Chan, TT; Bai, CH; You, SL; Chiou, HY; Su, TC; Chen, CJ | Atherosclerosis 210:585-589 | | | |
2014 | PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2. | Kuo, HY; Huang, YS; Tseng, CH; Chen, YC; Chang, YW; Shih, HM; Wu, CW | CELL CYCLE 13(19), 3132-42 | | | |
2022 | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine | Park, J; Le, AK; Tseng, TC; Yeh, ML; Jun, DW; Trinh, H; Wong, GLH; Chen, CH; Peng, CY; Kim, SE; Oh, H; Kwak, MS; Cheung, KS; Toyoda, H; Hsu, YC; Jeong, JY; Yoon, EL; Ungtrakul, T; Zhang, J; Xie, Q; Ahn, SB; Enomoto, M; Shim, JJ; Cunningham, C; Jeong, SW; Cho, YK; Ogawa, E; Huang, R; Lee, DH; Takahashi, H; Tsai, PC; Huang, CF; Dai, CY; Tseng, CH; Yasuda, S; Kozuka, R; Li, J; Wong, C; Wong, CC; Zhao, C; Hoang, J; Eguchi, Y; Wu, C; Tanaka, Y; Gane, E; Tanwandee, T; Cheung, R; Yuen, MF; Lee, HS; Yu, ML; Kao, JH; Yang, HI ; Nguyen, MH | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20(4), 874-885.e4 | | | |
2014 | TNFR1-JNK signaling is the shared pathway of neuroinflammation and neurovascular damage after LPS-sensitized hypoxic-ischemic injury in the immature brain | Wang, LW; Chang, YC; Chen, SJ; Tseng, CH; Tu ,YF; Liao, NS ; Huang, CC; Ho, CJ | J. Neuroinflammation 11, 215-229 | | | |